tisotumab vedotin-tftv 40 MG Injection

RxCUI: 2571099
RxNorm name: tisotumab vedotin-tftv 40 MG Injection
Display name: tisotumab vedotin-tftv 40 MG Injection
Full name: tisotumab vedotin-tftv 40 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761208	Tivdak	tisotumab vedotin-tftv	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TIVDAK	TISOTUMAB VEDOTIN	SEAGEN INC.	c9fe3f32-4219-466e-acb9-3f609b4f4df1	2025-11-20	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2571099

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c9fe3f32-4219-466e-acb9-3f609b4f4df1	tisotumab vedotin-tftv 40 MG Injection	SCD	10	These highlights do not include all the information needed to use TIVDAK safely and effectively. See full prescribing information for TIVDAK. TIVDAK ® (tisotumab vedotin-tftv) for injection, for intravenous use Initial U.S. Approval: 2021	20251120
c9fe3f32-4219-466e-acb9-3f609b4f4df1	tisotumab vedotin-tftv 40 MG Injection	PSN	10	These highlights do not include all the information needed to use TIVDAK safely and effectively. See full prescribing information for TIVDAK. TIVDAK ® (tisotumab vedotin-tftv) for injection, for intravenous use Initial U.S. Approval: 2021	20251120